These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 35704747)

  • 1. A new era in cytomegalovirus vaccinology: considerations for rational design of next-generation vaccines to prevent congenital cytomegalovirus infection.
    Nelson CS; Herold BC; Permar SR
    NPJ Vaccines; 2018; 3():38. PubMed ID: 30275984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytomegalovirus Vaccines: Current Status and Future Prospects.
    Anderholm KM; Bierle CJ; Schleiss MR
    Drugs; 2016 Nov; 76(17):1625-1645. PubMed ID: 27882457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Desirability and feasibility of a vaccine against cytomegalovirus.
    Griffiths P; Plotkin S; Mocarski E; Pass R; Schleiss M; Krause P; Bialek S
    Vaccine; 2013 Apr; 31 Suppl 2(Suppl 2):B197-203. PubMed ID: 23598482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a Vaccine against Human Cytomegalovirus: Advances, Barriers, and Implications for the Clinical Practice.
    Scarpini S; Morigi F; Betti L; Dondi A; Biagi C; Lanari M
    Vaccines (Basel); 2021 May; 9(6):. PubMed ID: 34070277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insight for Immunotherapy of HCMV Infection.
    Long X; Qiu Y; Zhang Z; Wu M
    Int J Biol Sci; 2021; 17(11):2899-2911. PubMed ID: 34345215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human Cytomegalovirus Infection and Neurocognitive and Neuropsychiatric Health.
    Gale SD; Farrer TJ; Erbstoesser R; MacLean S; Hedges DW
    Pathogens; 2024 May; 13(5):. PubMed ID: 38787269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell-mediated immunity to human CMV infection: a brief overview.
    Terrazzini N; Kern F
    F1000Prime Rep; 2014; 6():28. PubMed ID: 24860650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Humoral Immune Response Against the gB Vaccine: Lessons Learnt from Protection in Solid Organ Transplantation.
    Gomes AC; Griffiths PD; Reeves MB
    Vaccines (Basel); 2019 Jul; 7(3):. PubMed ID: 31319553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccines for Perinatal and Congenital Infections-How Close Are We?
    Singh T; Otero CE; Li K; Valencia SM; Nelson AN; Permar SR
    Front Pediatr; 2020; 8():569. PubMed ID: 33384972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leveraging preclinical study designs to close gaps in vaccine development for perinatal pathogens.
    Crooks CM; Chan C; Permar SR
    J Exp Med; 2023 Jul; 220(7):. PubMed ID: 37289272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human Cytomegalovirus (HCMV) Genetic Diversity, Drug Resistance Testing and Prevalence of the Resistance Mutations: A Literature Review.
    Grgic I; Gorenec L
    Trop Med Infect Dis; 2024 Feb; 9(2):. PubMed ID: 38393138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multivalent cytomegalovirus glycoprotein B nucleoside modified mRNA vaccines did not demonstrate a greater antibody breadth.
    Wang HY; Li L; Nelson CS; Barfield R; Valencia S; Chan C; Muramatsu H; Lin PJC; Pardi N; An Z; Weissman D; Permar SR
    NPJ Vaccines; 2024 Feb; 9(1):38. PubMed ID: 38378950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of Epstein-Barr-Virus (EBV)-Associated Cancers by Co-Infections.
    Münz C
    Cancers (Basel); 2023 Dec; 15(24):. PubMed ID: 38136285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytomegalovirus Pneumonia in Inflammatory Bowel Disease: Literature Review and Clinical Recommendations.
    Ren K; Yong C; Wang Y; Wei H; Zhao K; He B; Cui M; Chen Y; Wang J
    Infect Drug Resist; 2023; 16():6195-6208. PubMed ID: 37724090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary, Secondary, and Tertiary Prevention of Congenital Cytomegalovirus Infection.
    Sartori P; Egloff C; Hcini N; Vauloup Fellous C; Périllaud-Dubois C; Picone O; Pomar L
    Viruses; 2023 Mar; 15(4):. PubMed ID: 37112800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lessons from Acquired Natural Immunity and Clinical Trials to Inform Next-Generation Human Cytomegalovirus Vaccine Development.
    Hu X; Wang HY; Otero CE; Jenks JA; Permar SR
    Annu Rev Virol; 2022 Sep; 9(1):491-520. PubMed ID: 35704747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent Approaches and Strategies in the Generation of Anti-human Cytomegalovirus Vaccines.
    Boppana SB; Britt WJ
    Methods Mol Biol; 2021; 2244():403-463. PubMed ID: 33555597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maternal immune correlates of protection against placental transmission of cytomegalovirus.
    Itell HL; Nelson CS; Martinez DR; Permar SR
    Placenta; 2017 Dec; 60 Suppl 1(Suppl 1):S73-S79. PubMed ID: 28456432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advancing Our Understanding of Protective Maternal Immunity as a Guide for Development of Vaccines To Reduce Congenital Cytomegalovirus Infections.
    Permar SR; Schleiss MR; Plotkin SA
    J Virol; 2018 Apr; 92(7):. PubMed ID: 29343580
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.